Evidence map›Paper›PMID 35169540›Full record

ArticleRespiratory medicine case reports2022

Antineutrophil cytoplasmic antibody-negative granulomatosis with polyangiitis localized to the lungs.

Yuichi Ohteru, Kazuki Hamada, Keiji Oishi, Junki Suizu, Misa Harada, Keita Murakawa, Ayumi Chikumoto, Kazuki Matsuda, Sho Uehara, Shuichiro Ohata and 10 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Respiratory medicine case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 1 country.

Yuichi OhteruDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Japan.
Kazuki HamadaDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Japan.
Keiji OishiDepartment of Medicine and Clinical Science, Graduate School of Medicine, Yamaguchi University, Japan.
Junki SuizuDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Japan.
Misa HaradaDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Japan.
Keita MurakawaDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Japan.
Ayumi ChikumotoDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Japan.
Kazuki MatsudaDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Japan.
Sho UeharaDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Japan.
Shuichiro OhataDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Japan.
Yoriyuki MurataDepartment of Medicine and Clinical Science, Graduate School of Medicine, Yamaguchi University, Japan.
Yoshikazu YamajiDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Japan.
Kenji SakamotoDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Japan.
Maki Asami-NoyamaDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Japan.
Nobutaka EdakuniDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Japan.
Tsunahiko HiranoDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Japan.
Tomoyuki KakugawaDepartment of Pulmonary and Gerontology, Graduate School of Medicine, Yamaguchi University, Japan.
Tomoyuki MurakamiDepartment of Pathology, National Hospital Organization Kanmon Medical Center, Japan.
Tamiko TakemuraDepartment of Pathology, Kanagawa Cardiovascular and Respiratory Center, Japan.
Kazuto MatsunagaDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Japan.
Yamaguchi University · JPKanagawa Cardiovascular and Respiratory Center · JPNational Hospital Organization · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with granulomatosis with polyangiitis (GPA), formerly known as Wegener's granulomatosis, sometimes exhibit no clinical features. Here, we describe a case of antineutrophil cytoplasmic antibody (ANCA)-negative GPA presenting with only lung granuloma. A 55-year-old woman with a right upper lung mass underwent lobectomy for suspected lung cancer; however, only granuloma was detected, and the etiology was not identified. Serum ANCA results were negative. Four years postoperatively, another pulmonary nodule appeared in the left lung's apex. The kidneys and sinuses were not impaired, but re-examination of the resected specimen revealed necrotizing vasculitis and granulomas around the vessels. Thus, the patient was diagnosed with GPA localized to the lungs. Although this was a non-life-threatening disease, the patient was administered oral prednisolone (PSL) and intravenous cyclophosphamide (IVCY) to prevent fatal complications of GPA as she was non-elderly and had no comorbidities, leading to a decrease in the mass size. Detailed re-examination by expert pulmonary pathologists could aid in GPA diagnosis when clinical features are absent, as in our case. In patients with granulomas of unknown etiology, a careful multidisciplinary approach is pivotal in the diagnosis. If patients tolerate adverse effects, a PSL and IVCY combination may prevent fatal outcomes, even in patients with non-life-threatening disease.

Indexed as

Antineutrophil cytoplasmic antibodyGranuloma of unknown causeLocalized granulomatosis with polyangiitisNon-life-threatening disease

Identifiers

PMID35169540
PMCPMC8829757
OpenAlexW4212834223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.